Navigation Links
Delaying The Progression Of Alzheimer’s Disease

Researchers say for the first time, a drug seems to slightly delay the progress from memory impairment to Alzheimer’s disease.//

Previous studies have shown that without treatment, about 10 percent to 15 percent of patients with mild cognitive impairment will progress to Alzheimer’s disease each year. However, not every patient with the condition will progress to Alzheimer’s.

Researchers compared vitamin E, the Alzheimer’s treatment drug donepezil (Aricept), and a placebo for delay or prevention of progression from mild cognitive impairment to Alzheimer’s disease. They found vitamin E had no effect, but for a brief time, donepezil reduced the risk of progressing to Alzheimer’s when compared to patients who took a placebo.

The average delay in progression was about six months. Even though patients on donepezil progressed to Alzheimer’s at a slower rate than those on vitamin E or a placebo, the reduction in risk was short term. By the end of the study, all three treatment groups had the same risk of progression to Alzheimer’s disease.

Researchers say they are optimistic that they have now begun to make progress toward delaying the development of Alzheimer’s disease and the cognitive decline that accompanies it .However researchers say they are unsure why donepezil’s effects dropped off over time. They speculate that either the drug’s effect wore off after 18 months or that the drug exerts a modest effect, and then the disease process outweighs the chemical effect of th drug.
'"/>




Page: 1

Related medicine news :

1. Delaying Parkinson’s Diseas
2. The Effects Of Delaying A Delivery Questioned
3. Delaying pregnancy may lessen life expectancy of the child
4. UK Facing Shortage of Radiotherapists Delaying Cancer Treatment
5. Delaying Hernia Surgery Is Considered A Safe Option
6. Progression of Glaucoma could be controlled with early detection
7. Shyness Linked To HIV Progression
8. Stopping The Progression Of Parkinsons Disease
9. Contact Lenses Found To Slow Progression Of Myopia in Kids
10. Arithmetic Skills Found To Diminish With Progression Of Alzheimer’s Disease
11. Slowing Down The Progression Of Alzheimer’s Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... , ... January 21, 2017 , ... ... Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual meeting ... family, friends, and community. “Coming Home 2017” will be held on Friday ...
(Date:1/21/2017)... ... January 21, 2017 , ... In the United States, 20 ... the freedom of recovery, they often feel shame for having struggled with an eating ... (PTSD). In the workshop, “Rising Strong in Life After an Eating Disorder” -- to ...
(Date:1/20/2017)... ... ... A new partnership between Goodwill® and Roadie, Inc. aims to make it ... to couches to dressers and bicycles. Roadie — the national on-the-way delivery network — ... center through February 28th. , “January is an exciting time when resolutions are ...
(Date:1/20/2017)... ... January 20, 2017 , ... Doctor C LLC, a ... the January ECRM trade show to continue the marketing and distribution of its product, ... known for providing 400 percent better absorption than traditional vitamin C supplements. At the ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, ... everyday lives, recently attended the January ECRM Trade Show in Hilton Head, SC, ... for its large range of supplements that keep the body functioning at its ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... , Jan 20, 2017 Research and Markets ... Analysis & Trends - Technology, Route Of Administration, End User - ... ... is poised to grow at a CAGR of around 7.8% over ... This industry report analyzes the global markets for Advanced ...
(Date:1/20/2017)... -- Stock-Callers.com today evaluates the following Drug Manufacturers ... Nordisk A/S (NYSE: NVO ), Sucampo Pharmaceuticals Inc. ... (NASDAQ: PTX ). These stocks belong to the ... 2017, finishing near its session lows. As per a NASDAQ ... shares of health care companies in the S&P 500 also ...
(Date:1/20/2017)... 20, 2017 Avillion LLP, a co-developer and ... Mark Weinberg , MD MBA as Chief Medical Officer. Dr Weinberg ... USA . ... Dr Weinberg has spent more than 17 years as a pharmaceutical ... to micro-cap biotech. Over the course of his career, he has ...
Breaking Medicine Technology: